ClinVar Miner

Submissions for variant NC_000011.9:g.(?_532631)_(534375_?)dup

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine RCV000156408 SCV000206126 uncertain significance not specified 2014-07-31 criteria provided, single submitter clinical testing A whole gene gain of HRAS was identified in one individual with fetal hydrops, w hich was inherited from an unaffected parent (LMM unpublished). It is unknown if that gain extended beyond the HRAS gene. Additionally, copy number gains of a r egion encompassing HRAS and 12 other genes have been reported in 3 individuals w ith congenital heart defects (1 individual with coarctation of aorta who had Tur ner syndrome, 1 individual with double inlet left ventricle, and 1 individual wi th subaortic stenosis). These copy number gains have not been identified in 5812 control individuals (Tomita-Mitchell, 2012). The exact breakpoints of this HRAS whole gene duplication are not known and the duplication may extend well beyond the HRAS gene. Gain of function in HRAS is an established disease mechanism for Costello syndrome, though the functional impact of a whole gene duplication rem ains unclear. In summary, the clinical significance of this duplication is uncer tain.
Labcorp Genetics (formerly Invitae), Labcorp RCV000461310 SCV000563972 uncertain significance Costello syndrome 2016-10-16 criteria provided, single submitter clinical testing A gross duplication of the genomic region encompassing the full coding sequence of the HRAS gene has been identified. The boundaries of this event are unknown as the duplication extends beyond the assayed region for this gene and therefore may encompass additional genes. As the precise location of this duplication is unknown, it may be in tandem or it may be located elsewhere in the genome. Whole gene duplications of HRAS have not been reported in the literature in individuals with a HRAS-related disease. In summary, the exact genomic location of this variant is unknown and the impact of this duplication on HRAS protein function has not been established. Therefore, it has been classified as a Variant of Uncertain Significance.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.